The global continuous glucose monitoring devices market size is estimated to be USD 4,015.3 million in 2021 and is expected to witness a CAGR of 12.5% during the forecast period. Rising adoption of glucose monitoring devices owing to increasing incidence of diabetes is driving the global market growth. Moreover, availability of user-friendly & effective monitoring of glucose level monitoring devices, increase in technological advancements, digital penetration, and favorable government initiatives are other drivers propelling the market growth. However, inadequate commercial availability and lack of awareness in remote locations are expected to restrain the growth.

By Components

Based on components, the market is categorized into sensors, transmitters, receivers, and others. In 2021, the sensors segment accounted for a significant revenue share as it is in an integral part of medical monitoring device. This segment is driven by technological advancements and rising number of home care settings. Transmitter segment is anticipated to grow at a significant CAGR during the forecast period.

By EndUser

Based on enduser, the market is categorized into hospitals, in-house settings, and others. In-house settings segment accounted for the highest revenue in 2021 and is projected to maintain its dominance over the forecast period. The segment is driven by huge adoption of these products owing to its advantages such as regular monitoring of blood glucose level. Hospitals segment is projected to grow at a lucrative CAGR during the forecast period. Increase in number of visits of diabetic patients in hospitals is expected to drive the market for these products in hospitals.

Regional Insights

In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the increasing prevalence of diabetes, technological advancements, favorable research & development policies, and government initiatives to control the prevalence of diabetes. Asia Pacific is projected to grow atthe fastest CAGR over the forecast period owing to rising awareness about diabetes monitoring devices, product expansion by leading device manufacturers, increasing R&D, and large geriatric population base.

Competitor Insights

Some of the major companies in the continuous glucose monitoring devices market are F. Hoffmann-La Roche AG (Switzerland), Medtronic plc (Ireland), Abbott Laboratories (U.S.), DexCom, Inc. (U.S.), Johnson & Johnson (U.S.), Novo Nordisk A/S (Denmark), GlySens ICGM (U.S.), Ypsomed Holding (Switzerland), Boston Scientific Corporation (U.S.), and Becton, Dickinson and Company (U.S.). The leading players have adopted strategic collaborations, mergers & acquisitions, market expansion, and novel product development approaches to capture the market share.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country-level along with key market trends and dynamics from 2021 to 2029. The continuous glucose monitoring devices market report is categorized into the following segments and subsegments:

Continuous Glucose Monitoring Devices Market, By Components (Revenue, 2021-2029, USD Million)

Continuous Glucose Monitoring Devices Market, By End-User (Revenue, 2021-2029, USD Million)

Continuous Glucose Monitoring Devices Market, By Region (Revenue, 2021-2029, USD Million)

Scope of Continuous Glucose Monitoring Devices Market Report:

Key Parameters	Details
Base Year	2021
Forecast Period	2022-2029
Study Coverage	Global and regional market size and revenue forecast Segment market size and revenue forecast at global, regional, and country level Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis) Conclusion and recommendations
Qualitative Analysis	Market drivers Market restraints Market opportunities Recent market trends Market challenges Porter’s Five Forces analysis PEST analysis Value-chain analysis COVID-19 impact analysis
Regional Market Scope	North America (U.S. and Canada) Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe) Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC) Latin America (Brazil, Mexico, Argentina, Rest of LATAM) MEA (South Africa, GCC, Rest of MEA)
Company Profiles	Exhaustive profiles of top 10 players 50+ other major players listing
15% Free Customization Available	You can customize the study scope to meet your exact requirement. Click here for more details